IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.12% | 333.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.12% | 333.33% | |||
| Cost of Revenue | -33.72% | -92.75% | |||
| Gross Profit | 33.33% | 101.55% | |||
| SG&A Expenses | -23.62% | -29.44% | |||
| Depreciation & Amortization | 1.45% | -90.19% | |||
| Other Operating Expenses | 10.13% | -30.73% | |||
| Total Operating Expenses | -2.86% | -45.82% | |||
| Operating Income | 2.22% | 47.36% | |||
| Income Before Tax | 48.99% | -7.81% | |||
| Income Tax Expenses | -2,250.00% | 101.64% | |||
| Earnings from Continuing Operations | 50.05% | -11.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.05% | -11.40% | |||
| EBIT | 2.22% | 47.36% | |||
| EBITDA | 5.16% | 45.10% | |||
| EPS Basic | 86.09% | 29.29% | |||
| Normalized Basic EPS | -240.00% | 97.14% | |||
| EPS Diluted | 85.95% | 29.29% | |||
| Normalized Diluted EPS | -240.00% | 97.14% | |||
| Average Basic Shares Outstanding | 259.37% | 57.52% | |||
| Average Diluted Shares Outstanding | 259.37% | 57.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||